Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€6.00
09.03.24
€7.50
09.03.25
73.33%
30.08.24

Could be worthwhile Investment >10% per year
melinda 
09.03.24 20%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€64.50
08.03.24
-
08.03.25
-8.53%
15.03.24

Could be worthwhile Investment >10% per year
Global_Player 
08.03.24 50%
buy
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.53
07.03.24
€4.58
07.03.25
206.41%
02.09.24

Benchmark Co. 
07.03.24 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.40
07.03.24
€3.67
07.03.25
-47.24%
26.06.24

Citigroup Inc. 
07.03.24 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€28.20
07.03.24
€41.38
07.03.25
-51.06%
30.08.24

JPMorgan Chase & Co. 
07.03.24 50%
buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€14.95
07.03.24
€21.15
07.03.25
22.42%
02.09.24

Bank of America Co. 
07.03.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€220.00
07.03.24
€298.84
07.03.25
49.59%
02.09.24

Wells Fargo & Company 
07.03.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.65
06.03.24
€66.11
06.03.25
6.00%
02.09.24

Oppenheimer Holdings Inc. 
06.03.24 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.41
06.03.24
€13.77
06.03.25
-47.37%
26.06.24

HC Wainwright 
06.03.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.96
06.03.24
€6.43
06.03.25
-77.90%
30.08.24

HC Wainwright 
06.03.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€60.00
06.03.24
€90.93
06.03.25
-8.33%
02.09.24

Mizuho 
06.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
6.69%
06.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Purple Biotech Ltd. ADR

Start price
Target price
Perf. (%)
€0.70
05.03.24
€9.21
05.03.25
-46.00%
30.08.24

HC Wainwright 
05.03.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€138.00
05.03.24
€363.68
05.03.25
72.10%
02.09.24

HC Wainwright 
05.03.24 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€201.60
05.03.24
€334.73
05.03.25
-7.89%
02.09.24

Royal Bank of Canada 
05.03.24 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€26.60
05.03.24
€38.62
05.03.25
-9.70%
20.08.24

UBS Group AG 
05.03.24 50%
buy
Cara Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.78
05.03.24
€4.61
05.03.25
-58.43%
30.08.24

Needham & Company LLC 
05.03.24 50%
sell
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€1.33
05.03.24
€0.94
05.03.25
-61.90%
02.09.24

HSBC Holdings plc 
05.03.24 50%
buy
Cellectar BioSciences Inc.

Start price
Target price
Perf. (%)
€3.68
04.03.24
€18.41
04.03.25
-45.92%
02.09.24

Roth Mkm 
04.03.24 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€66.00
04.03.24
€98.59
04.03.25
-16.67%
02.09.24

Oppenheimer Holdings Inc. 
04.03.24 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€26.20
04.03.24
€52.53
04.03.25
-47.33%
30.08.24

HC Wainwright 
04.03.24 50%
buy
GSK plc ADR

Start price
Target price
Perf. (%)
€38.80
04.03.24
-
04.03.25
2.82%
02.09.24

Guggenheim 
04.03.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.63
04.03.24
€1.00
04.03.25
-12.50%
08.03.24

Could be worthwhile Investment >10% per year
melinda 
04.03.24 20%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€25.60
04.03.24
-
04.03.25
-0.78%
15.03.24

Risky Investment
michaelkr 
04.03.24 50%
sell
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€4.00
04.03.24
-
04.03.25
-13.00%
16.03.24

Probably not worthwhile Investment
daimler1 
04.03.24 50%